Imatinib Mesylate [imatinib mesylát]
- Terms
-
Glivec
imatinib
-
Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide
CGP 57148
CGP-57148
CGP57148B
Gleevec
Glivec
Imatinib
Imatinib Methanesulfonate
ST 1571
ST1571
STI 571
STI-571
STI571
A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.
- DUI
- D000068877 MeSH Browser
- CUI
- M0391958
- History note
- 2016 (1996)
- Public note
- 2016; IMATINIB MESYLATE was indexed under BENZAMIDES, PIPERAZINES, and PYRIMIDINES 1996-2015
Allowable subheadings
- AD
- administration & dosage 27
- AE
- adverse effects 24
- AG
- agonists
- AA
- analogs & derivatives 1
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood 5
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification
- EC
- economics 2
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 1
- PK
- pharmacokinetics 2
- PD
- pharmacology 29
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 78
- TO
- toxicity 1
- UR
- urine 1